BioCorteX

PITCH

Not everyone responds to medications BioCorteX will change this by leveraging the relationship between bacteria and medications We are developing the world's first clinically validated, knowledge-driven, human-microbiome platform that we will use to develop our own therapeutic pipeline. BioCorteX is a 'techbio' that applies deep technology to deliver effective therapeutics by leveraging the synergy between health and bacteria, viruses, and fungi. We exist because current drug development fails individuals by ignoring the (un)desirable drug-microbiome interactions.

Based in

London

Created in

> Website

LATEST INVESTMENT

#Medtech 04.2023

£4M

Sofinnova Partners & Hoxton Ventures